Pirtobrutinib (LOXO-305), a next generation highly selective non-covalent Bruton's tyrosine kinase inhibitor in previously treated mantle cell lymphoma and other non-Hodgkin lymphomas: Results from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Eyre, T.; Shah, N. N.; Alencar, A.; Gerson, J. N.; Patel, M. R.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; Coombs, C. C.; Flinn, I.; Lewis, D.; Le Gouill, S.; Palomba, M. L.; Woyach, J.; Pagel, J. M.; Lamanna, N.; Cohen, J. B.; Barve, M. A.; Ghia, P.; Yin, M.; Nair, B.; Tsai, D. E.; Ku, N. C.; Mato, A. R.; Cheah, C. Y.; Wang, M. L. |
| Abstract Title: | Pirtobrutinib (LOXO-305), a next generation highly selective non-covalent Bruton's tyrosine kinase inhibitor in previously treated mantle cell lymphoma and other non-Hodgkin lymphomas: Results from the phase 1/2 BRUIN study |
| Meeting Title: | 61st Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 193 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Apr 25-28 |
| Meeting Location: | Virtual |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-04-01 |
| Start Page: | 142 |
| End Page: | 143 |
| Language: | English |
| ACCESSION: | WOS:000645412200188 |
| PROVIDER: | wos |
| PUBMED: | 33928641 |
| DOI: | 10.1111/bjh.17492 |
| Notes: | Meeting Abstract: BSH2021-PO-145 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work